Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

The FDA has classified the correction of epidural kits containing Spectra Medical Devices Lidocaine Ampules as a Class I Recall due to potential risks of serious injury or death associated with the affected sodium chloride ampules. Medical Action Industries has advised customers to quarantine these kits until they can be corrected.

What changed: The FDA has classified the issue as a Class I Recall, marking it as the most serious type of recall due to risks of serious injury or death.

Why it matters: This classification requires immediate attention from healthcare providers and manufacturers to prevent potential harm associated with the use of these products.

Practical implication: Healthcare providers should quarantine all impacted epidural kits and remove any sodium chloride ampules affected by this recall, implementing corrective actions per FDA guidance.

• Recalls, Market Withdrawals and Safety Alerts
• Warning Letters
• Safety
• Inspections and Compliance
• Medical Device Safety
• Medical Device Recalls and Early Alerts
• What is a Medical Device Recall?
• What is an Early Alert?

View original source

• Source: FDA - MedWatch Safety Alerts RSS
• Published at source: 2026-09-10T00:00:00.000Z
• Discovered by monitor: 2026-09-10T21:31:33.991Z

Published from the regulator source ingestion pipeline after PV impact triage.